- call +1-201-465-4211
- email sales@mrinsights.biz
Anti-infective vaccines are the most effective public health measure taken to fight infectious diseases.
Scope of the Report:
This report focuses on the Anti-Infective Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Anti-Infective Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Emergent BioDefense Operations Lansing Inc.
Sanofi Pasteur
Merck & Co.
MedImmune LLC
Novartis Vaccines
Diagnostics Ltd.
Intercell Biomedical
MassBiologics
Barr Labs, Inc.
Organon Teknika Co.
GlaxoSmithKline Biologicals
CSL Ltd.
ID Biomedical Co.
Protein Sciences Co.
Wyeth Pharmaceuticals, Inc.
Berna Biotech
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Inactivated vaccines
Conjugate vaccines
Live/attenuated vaccines
Market Segment by Applications, can be divided into
Bacterial diseases
Viral diseases
There are 15 Chapters to deeply display the global Anti-Infective Vaccines market.
Chapter 1, to describe Anti-Infective Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-Infective Vaccines, with sales, revenue, and price of Anti-Infective Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Infective Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-Infective Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-Infective Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anti-Infective Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Inactivated vaccines
1.2.2 Conjugate vaccines
1.2.3 Live/attenuated vaccines
1.3 Market Analysis by Applications
1.3.1 Bacterial diseases
1.3.2 Viral diseases
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Emergent BioDefense Operations Lansing Inc.
2.1.1 Business Overview
2.1.2 Anti-Infective Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi Pasteur
2.2.1 Business Overview
2.2.2 Anti-Infective Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck & Co.
2.3.1 Business Overview
2.3.2 Anti-Infective Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck & Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 MedImmune LLC
2.4.1 Business Overview
2.4.2 Anti-Infective Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis Vaccines
2.5.1 Business Overview
2.5.2 Anti-Infective Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Diagnostics Ltd.
2.6.1 Business Overview
2.6.2 Anti-Infective Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Intercell Biomedical
2.7.1 Business Overview
2.7.2 Anti-Infective Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Intercell Biomedical Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 MassBiologics
2.8.1 Business Overview
2.8.2 Anti-Infective Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 MassBiologics Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Barr Labs, Inc.
2.9.1 Business Overview
2.9.2 Anti-Infective Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Organon Teknika Co.
2.10.1 Business Overview
2.10.2 Anti-Infective Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 GlaxoSmithKline Biologicals
2.11.1 Business Overview
2.11.2 Anti-Infective Vaccines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 CSL Ltd.
2.12.1 Business Overview
2.12.2 Anti-Infective Vaccines Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 ID Biomedical Co.
2.13.1 Business Overview
2.13.2 Anti-Infective Vaccines Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Protein Sciences Co.
2.14.1 Business Overview
2.14.2 Anti-Infective Vaccines Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Wyeth Pharmaceuticals, Inc.
2.15.1 Business Overview
2.15.2 Anti-Infective Vaccines Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Berna Biotech
2.16.1 Business Overview
2.16.2 Anti-Infective Vaccines Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Berna Biotech Anti-Infective Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-Infective Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti-Infective Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Infective Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Infective Vaccines Manufacturer Market Share in 2017
3.3.2 Top 6 Anti-Infective Vaccines Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti-Infective Vaccines Market Analysis by Regions
4.1 Global Anti-Infective Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Infective Vaccines Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti-Infective Vaccines Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
4.3 Europe Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
4.5 South America Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
5 North America Anti-Infective Vaccines by Countries
5.1 North America Anti-Infective Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Infective Vaccines Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti-Infective Vaccines Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
5.3 Canada Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
5.4 Mexico Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
6 Europe Anti-Infective Vaccines by Countries
6.1 Europe Anti-Infective Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Infective Vaccines Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti-Infective Vaccines Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
6.3 UK Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
6.4 France Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
6.5 Russia Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
6.6 Italy Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti-Infective Vaccines by Countries
7.1 Asia-Pacific Anti-Infective Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Infective Vaccines Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Infective Vaccines Revenue and Market Share by Countries (2013-2018)
7.2 China Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
7.3 Japan Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
7.4 Korea Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
7.5 India Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
8 South America Anti-Infective Vaccines by Countries
8.1 South America Anti-Infective Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Infective Vaccines Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti-Infective Vaccines Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
8.3 Argentina Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
8.4 Colombia Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti-Infective Vaccines by Countries
9.1 Middle East and Africa Anti-Infective Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Infective Vaccines Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Infective Vaccines Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
9.3 UAE Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
9.4 Egypt Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
9.6 South Africa Anti-Infective Vaccines Sales and Growth Rate (2013-2018)
10 Global Anti-Infective Vaccines Market Segment by Type
10.1 Global Anti-Infective Vaccines Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Infective Vaccines Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Infective Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Inactivated vaccines Sales Growth and Price
10.2.1 Global Inactivated vaccines Sales Growth (2013-2018)
10.2.2 Global Inactivated vaccines Price (2013-2018)
10.3 Conjugate vaccines Sales Growth and Price
10.3.1 Global Conjugate vaccines Sales Growth (2013-2018)
10.3.2 Global Conjugate vaccines Price (2013-2018)
10.4 Live/attenuated vaccines Sales Growth and Price
10.4.1 Global Live/attenuated vaccines Sales Growth (2013-2018)
10.4.2 Global Live/attenuated vaccines Price (2013-2018)
11 Global Anti-Infective Vaccines Market Segment by Application
11.1 Global Anti-Infective Vaccines Sales Market Share by Application (2013-2018)
11.2 Bacterial diseases Sales Growth (2013-2018)
11.3 Viral diseases Sales Growth (2013-2018)
12 Anti-Infective Vaccines Market Forecast (2018-2023)
12.1 Global Anti-Infective Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Infective Vaccines Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Infective Vaccines Market Forecast (2018-2023)
12.2.2 Europe Anti-Infective Vaccines Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Infective Vaccines Market Forecast (2018-2023)
12.2.4 South America Anti-Infective Vaccines Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Infective Vaccines Market Forecast (2018-2023)
12.3 Anti-Infective Vaccines Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Infective Vaccines Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Infective Vaccines Market Share Forecast by Type (2018-2023)
12.4 Anti-Infective Vaccines Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Infective Vaccines Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Infective Vaccines Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti-Infective Vaccines Picture
Table Product Specifications of Anti-Infective Vaccines
Figure Global Sales Market Share of Anti-Infective Vaccines by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
